SY001

· Cell Origin Biotech (Hangzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SY001, covering 2026-02-13 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors [NA]